Skip to main content

Table 3 Schedule for data collection during the GOSPEL 1 trial

From: Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

  Study period  
Enrolment Allocation Post-allocation Close-out
Timepoint Pre-baseline Baseline Baseline 6 months* 12 months* 18 months
 Eligibility screen X      
 Informed consent X      
 Allocation   X     
 GOSPEL 1       
 Usual care       
 Recruitment (feasibility)      X  
 Barriers and facilitators of care: optional interviews (feasibility)      X  
 Satisfaction of care      X  
 Medications history    X    
 HRQoL (FACT-Lym)    X X X  
 Patient experience of care    X X X  
 Symptom distress    X X X  
 Comorbidity burden    X   X  
 Dietary intake    X X X  
 Physical activity    X X X  
 Financial distress    X X X  
 Employment interference    X X X  
Participant characteristics
 Demographics    X    
 Clinical characteristics    X    
Process Outcomes
 Intervention fidelity: completion of checklists       X
 Clinical encounters at cancer center       X
 Cost analysis: resources to conduct the intervention       X
 Safety indicators: clinical encounters, unscheduled clinic visits and rapid referrals back to acute care       X
  1. *Post-baseline